Los Angeles Company Falsely Announces FDA Authorization for Two-Minute COVID-19 Diagnostic Test
Share
[aggregation-styles]
Mobi Health News
On Tuesday morning, Los Angeles-based Bodysphere announced that it had received an Emergency Use Authorization (EUA) for a rapid COVID-19 serology test able to deliver results in as little as two minutes.
Word of the company product spread quickly across social media and several mainstream news publications, which highlighted the platform’s quick turnaround time, and the impact that such a test could have on identifying those who should or should not self-quarantine.
However, Bodysphere’s test was never acknowledged on the FDA’s running list of in vitro diagnostic products that have received an EUA. Other news outlets that had reached out to the FDA for confirmation of the authorization received statements clarifying that the agency has not yet issued an EUA to any serology diagnostics for COVID-19.
Within a single day, Business Wire – a platform that uploads and disseminates press releases to media – pulled Bodysphere’s announcement from its service, and several news outlets amended or fully retracted their coverage of the test. The company itself has since posted a statement from its CEO, Charlton E. Lui, describing the confusion as a misunderstanding on the part of Bodysphere.
Read More →
Mobi Health News
On Tuesday morning, Los Angeles-based Bodysphere announced that it had received an Emergency Use Authorization (EUA) for a rapid COVID-19 serology test able to deliver results in as little as two minutes.
Word of the company product spread quickly across social media and several mainstream news publications, which highlighted the platform’s quick turnaround time, and the impact that such a test could have on identifying those who should or should not self-quarantine.
However, Bodysphere’s test was never acknowledged on the FDA’s running list of in vitro diagnostic products that have received an EUA. Other news outlets that had reached out to the FDA for confirmation of the authorization received statements clarifying that the agency has not yet issued an EUA to any serology diagnostics for COVID-19.
Within a single day, Business Wire – a platform that uploads and disseminates press releases to media – pulled Bodysphere’s announcement from its service, and several news outlets amended or fully retracted their coverage of the test. The company itself has since posted a statement from its CEO, Charlton E. Lui, describing the confusion as a misunderstanding on the part of Bodysphere.
Read More →
By Dave Muoio | 20 Apr 2020
RELATED TOPICS:
Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients
Politics /
14 hours ago
Boeing Secures $2.8 Billion US Satellite Contract
Tech /
14 hours ago
Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County
Local /
14 hours ago
Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department
Politics /
15 hours ago
Fresno Police Recover Some of the $40,000 in Fireworks Stolen From Bullard High Team
Local /
16 hours ago
Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers
World /
16 hours ago
Fresno Crash Involving Unlicensed Teen Driver Sends Woman to Hospital
A two-vehicle collision sent a woman driving one of the vehicles to the hospital with a head injury Thursday afternoon in Fresno.
Fresno pol...
News /
12 hours ago
Categories
Latest
Videos

News /
12 hours ago
Fresno Crash Involving Unlicensed Teen Driver Sends Woman to Hospital

Politics /
14 hours ago
Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

Tech /
14 hours ago
Boeing Secures $2.8 Billion US Satellite Contract

Local /
14 hours ago
Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

Video /
18 hours ago